Pathologic Assessment of Neoadjuvant Treated Melanoma Specimens: Lessons learned along the way 6.29.26

June 29, 2026

Kidney cancer series

Code: RUTKOT

https://cce.upmc.com/content/pathologic-assessment-neoadjuvant-treated-melanoma-specimens-lessons-learned-along-way-62926

Target Audience

Physicians

Learning Objectives

Upon completion of this educational activity, the learner will be able to:

  1. Understand the significance of comprehensive gross assessment of neoadjuvant treated melanoma specimens
  2. Understand how to tabulate pathologic response following neoadjuvant therapy
  3. Understand the significance of the pathologic response
  4. Understand the significance of the composition of the pathologic response

Additional Information

AttachmentSize
Microsoft Office document icon How to access my credits_ Kidney cancer - Pathologic Assessment of Neoadjuvant Treated Melanoma Specimens Lessons learned along the way 6.29.26.doc95 KB
File Master Intro Slide for audience disclosure_ Kidney cancer-Pathologic Assessment of Neoadjuvant Treated Melanoma Specimens Lessons learned along the way 6.29.26.pptx50.73 KB
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 1.00 Attendance
Course opens: 
06/28/2026
Course expires: 
12/30/2026
Event starts: 
06/29/2026 - 12:00pm EDT
Event ends: 
06/29/2026 - 1:00pm EDT
Add to calendar: 

 

 

West Wing Auditorium, UPMC Shadyside Hospital
Pittsburgh, PA
United States

Conflict of Interest Disclosure: The following relevant financial relationships were disclosed: Michael Tetzlaff  serve on the speaker bureau for Merck and is a consultant for Merck, Regeneron, Elsevier.

 

No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

 

 

Accreditation and credit designation

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician (CME)

 The University of Pittsburgh School designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Healthcare Professionals

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 1.00 Attendance
Please login or register to take this course.